• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsKailera Therapeutics
    Picture of Kailera Therapeutics logo

    KLRA — Kailera Therapeutics News Story

    $19.900.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapSucker Stock
    • Market Cap
      $2.58bn
    • Enterprise Value
      $2.06bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • KLRA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    KLRA Dividends
    All News

    NASDAQ RESUMED AT 01:25 PM

    Picture of Kailera Therapeutics logoKailera Therapeutics
    17/04/2026 18:25
    NASDAQ RESUMED  KLRA.O  AT 01:25 PM
    

    Recent news on Kailera Therapeutics

    See all news
    • Kardigan surges in Nasdaq debut after upsized $400 million IPO (updated)

      18/06/2026 17:56
    • Brief: Kailera Therapeutics Says Phase 2 Ribupatide Oral Shows Up To 12.1% Mean Weight Loss At 26 Weeks

      06/06/2026 24:40
    • Advisory: Research alert on Kailera Therapeutics withdrawn

      14/05/2026 06:25
    • Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut (updated)

      08/05/2026 16:58
    • Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut

      08/05/2026 16:54

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.